Erick Lucera, EVP, CHIEF FINANCIAL OFFICER at Editas Medicine, Inc. (EDIT), sold 4,109 shares at $1.71 ($7K) on 2025-03-04, disclosed to the SEC on 2025-03-05.
Open-market sale of $7k EDIT by EVP, CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DYN | SELL | 2026-05-14 | $27K | — | Filing → |
| DYN | SELL | 2026-04-03 | $107K | — | Filing → |
| XAIR | BUY | 2024-08-15 | $16K | — | Filing → |